Principal Financial Group Inc Deciphera Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$13.58 - $17.36 $11,746 - $15,016	-865 Reduced 5.04%	16,303 $256,000
Q4 2023 Feb 07, 2024	SELL	$10.11 - $16.54 $11,100 - $18,160	-1,098 Reduced 6.01%	17,168 $276,000
Q3 2023 Nov 02, 2023	BUY	$12.46 - $15.48 $21,169 - $26,300	1,699 Added 10.26%	18,266 $232,000
Q2 2023 Aug 07, 2023	BUY	$13.28 - $15.96 $13,054 - $15,688	983 Added 6.31%	16,567 $233,000
Q1 2023 May 09, 2023	BUY	$14.26 - $22.1 $21,960 - $34,034	1,540 Added 10.97%	15,584 $240,000
Q4 2022 Feb 09, 2023	BUY	$14.85 - $19.04 $30,828 - $39,527	2,076 Added 17.35%	14,044 $230,000
Q3 2022 Nov 09, 2022	BUY	$12.38 - $20.23 $21,268 - $34,755	1,718 Added 16.76%	11,968 $221,000
Q2 2022 Aug 10, 2022	BUY	$9.11 - $13.98 $93,377 - $143,295	10,250 New	10,250 $134,000
Q4 2021 Feb 09, 2022	SELL	$7.7 - $37.13 $146,731 - $707,549	-19,056 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$26.46 - $37.15 $7,858 - $11,033	-297 Reduced 1.53%	19,056 $648,000
Q2 2021 Aug 10, 2021	SELL	$32.73 - $47.95 $49,880 - $73,075	-1,524 Reduced 7.3%	19,353 $708,000
Q1 2021 May 10, 2021	SELL	$40.39 - $56.73 $17,690 - $24,847	-438 Reduced 2.05%	20,877 $937,000
Q4 2020 Feb 08, 2021	BUY	$51.77 - $66.18 $249,531 - $318,987	4,820 Added 29.22%	21,315 $1.22 Million
Q3 2020 Nov 06, 2020	SELL	$43.8 - $58.16 $32,411 - $43,038	-740 Reduced 4.29%	16,495 $846,000
Q2 2020 Aug 05, 2020	BUY	$37.05 - $65.03 $358,162 - $628,645	9,667 Added 127.74%	17,235 $1.03 Million
Q1 2020 May 12, 2020	BUY	$33.63 - $69.4 $13,821 - $28,523	411 Added 5.74%	7,568 $312,000
Q4 2019 Feb 05, 2020	BUY	$31.7 - $69.93 $226,876 - $500,489	7,157 New	7,157 $445,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

343K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account